Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Phase 3 TRANSCEND-T2D-1 (March 19, 2026) showed 16.8% loss at 12 mg over 40 weeks in adults with type 2 diabetes
H.N., C.O., Y.T., J.T., H.Y., S.T., S.A., H.K., and K.Y.C
However, competitive pressure from Novo Nordisk's pipeline and the expansion of Medicare negotiated pricing may limit how much of a premium Lilly can charge
4-HNE: 4-hydroxynonenal
Trulicity remains an effective option for glucose control, particularly for those prioritising cardiovascular protection, but when weight loss is a central goal, Wegovy is often the more effective choice.
US$ 25.24
US$ 25.99
US$ 20.38
US$ 25.85
US$ 21.94
US$ 21.11
